Results 21 to 30 of about 17,947 (225)
Short-Term Daily Oral Administration of Cannabidiol Does Not Impact Rebound Tonometry Intraocular Pressure or Schirmer Tear Test Values in Healthy Adult Horses. [PDF]
Vet OphthalmolABSTRACT Objective To assess the effect of orally administered cannabidiol (CBD) on TonoVet measured intraocular pressure (IOP) and Schirmer tear test I (STT) in horses. Animal Studied Horse. Procedure This was a masked, randomized, balanced cross‐over study of six healthy adult horses.
Diehl K, Sheridan C, Reed R.
europepmc +2 more sources
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
Scientific Reports, 2021 Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children.
Nir Treves +6 more
doaj +1 more source
Passive exposure to cannabidiol oil does not cause microbiome dysbiosis in larval zebrafish
Current Research in Microbial Sciences, 2021 The use of cannabidiol oil derived products has dramatically increased in popularity and is predicted to grow steadily over the next decade. Given its relative stability, cannabidiol is likely to accumulate in the environment and affect aquatic animals ...
Maracela Talamantes +3 more
doaj +1 more source
Analyzing cannabinoid-induced abnormal behavior in a zebrafish model.
PLoS ONE, 2020 In this study, we investigated locomotor activity and responses to repeated light and dark stimuli to assess cannabinoid-induced abnormal behavior in zebrafish larvae (Danio rerio), as an alternative to standard rodent models.
Akihiro Hasumi +2 more
doaj +1 more source
The Lancet Regional Health. Europe, 2023 Summary: Background: Painful knee osteoarthritis (KOA) is common, pharmacological treatment, however, is often hampered by limited tolerability. Cannabidiol, which preclinically showed anti-inflammatory, analgesic activity, could supplement established ...
Sibylle Pramhas +6 more
doaj +1 more source
Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients
Medical Cannabis and Cannabinoids, 2023 Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol is primarily approved for childhood epileptic disorders Lennox-Gastaut and Dravet syndrome.
Edward Y. Liu +2 more
doaj +1 more source
Successful use of pure cannabidiol for the treatment of super-refractory status epilepticus
Epilepsy and Behavior Case Reports, 2018 We present the case of a child with long-standing, super-refractory status epilepticus (SRSE) who manifested prompt and complete resolution of SRSE upon exposure to pure cannabidiol.
Rajsekar R. Rajaraman +2 more
doaj +1 more source
Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis [PDF]
International Journal of Minor Fruits, Medicinal and Aromatic PlantsThe purpose of this study was to characterize the key patterns of cannabidiol metabolism and elimination. To fulfil this purpose, the study employed the latest scientific sources for the last 5-6 years from authoritative scientometric databases and ...
Oles-Pylyp Hasiuk
doaj +1 more source
Frontiers in Molecular Neuroscience, 2021 Cannabidiol, a compound of Cannabis sativa, has been proposed as an alternative treatment of schizophrenia. Preclinical and clinical data have suggested that cannabidiol shares more similarity with atypical antipsychotics than typical, both of which are ...
Ana Caroline Brambilla Falvella +12 more
doaj +1 more source